SCHEMBL29348206

SCHEMBL29348206

CC(C)N1Cc2nccn2CC1=O

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3226591 0.77 ADRA1A (0.31)
SCHEMBL29348293 0.73 ADRA1D (0.31)
SCHEMBL29348300 0.72 USP19 (0.33)
SCHEMBL9834032 0.70 MAPT (0.41)
SCHEMBL13290569 0.70 MAPT (0.41)
SCHEMBL13290579 0.70 MAPT (0.41)
SCHEMBL19164218 0.69 ADRA1A (0.31)
SCHEMBL13513137 0.67
SCHEMBL6510074 0.67 HRH1 (0.32) IDH1
SCHEMBL23349325 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024151547-A1 TARGETED DEGRADATION OF VAV1 MONTE ROSA THERAPEUTICS, INC. (US) 2024-07-18 WO disclosed